1. Genomic diversity of Helicobacter pylori and human migrations<div>Yoshio Yamaoka(Oita University, Japan) E-mail: yyamaoka@oita-u.ac.jp<div><br></div><div>2. Epidemiology, diagnosis and risk factors of Helicobacter pylori infections</div><div>Eliette Touati (Pasteur Institute, France) E-mail: eliette.touati@pasteur.fr</div><div><br></div><div>3. Activities and functional importance of Helicobacter pylori virulence factors</div><div>Dionyssios Sgouras (Pasteur Institute, France) E-mail: dionsgouras@gmail.com</div><div><br></div><div>4. Structural and functional aspects of the Helicobacter pylori proteome</div><div>Giuseppe Zanotti (University of Padova, Italy) E-mail: giuseppe.zanotti@unipd.it</div><div><br></div><div>5. Role of adhesion to epithelial cells in gastric colonization by H. pylori</div><div> Eric Sundberg (University of Maryland, USA) E-mail: esundberg@ihv.umaryland.edu</div><div><br></div><div>6. Interplay of Helicobacter pylori with immune cells: impact on gastric pathology</div><div>Steffen Backert (Friedrich-Alexander University Erlangen, Germany) E-mail: Ebook-Helicobacter@gmx.de</div><div><br></div><div>7. Helicobacter pylori infection of children</div><div>Masumi Okuda (Aichi Medical University, Japan) E-mail: okuda@naxnet.or.jp</div><div><br></div><div>8. Non-malignant Helicobacter pylori-associated diseases</div><div>Michael Vieth (Institute of Pathology, Germany) E-mail: vieth.lkpathol@uni-bayreuth.de</div><div><br></div><div>9. Malignant Helicobacter pylori-associated diseases: gastric cancer and MALT lymphoma</div><div>Masanori Hatakeyama (The University of Tokyo, Japan) E-mail: mhata@m.u-tokyo.ac.jp</div><div><br></div><div>10. Host genetic polymorphisms in gastric disease outcome</div><div>Margeruite Clyne (University College Dublin, Ireland) E-mail: marguerite.clyne@ucd.ie</div><div><br></div><div>11. Helicobacter pylori genetic polymorphisms in gastric disease development</div><div>Scott Merrell (Uniformed Services University of the Health Sciences, USA) E-mail: douglas.merrell@usuhs.edu</div><div><br></div><div>12. Crosstalk of Helicobacter pylori with the gastrointestinal microbiota</div><div>Ceu Figueiredo (University of Porto, Portugal) E-mail: cfigueiredo@ipatimup.pt</div><div><br></div><div>13. Treatment of Helicobacter pylori infection</div><div>Akiko Shiotani (Kawasaki Medical University, Japan) E-mail: shiotani@med.kawasaki-m.ac.jp</div><div><br></div><div>14. Role of probiotics in eradication therapy for Helicobacter pylori infection</div><div>Shigeru Kamiya (Kyorin University, Japan) E-mail: skamiya@ks.kyorin-u.ac.jp</div><div><br></div><div>15. Immunity and vaccine development against Helicobacter pylori</div><div>Anna Walduck (RMIT University, Australia) E-mail: anna.walduck@rmit.edu.au</div><div><br></div><div><br></div></div>
